Skip to main content

Bioinformatics Pioneer Chris Sander Accepts Position with Millennium

Premium

CAMBRIDGE, Mass.--Chris Sander, a researcher with the European Molecular Biology Laboratory (EMBL) who is internationally recognized as a pioneer in the field of bioinformatics, has agreed to serve as chief information officer of Millennium Information, a new spinoff from Millennium Pharmaceuticals here. In the new position Sander will lead the company "in conceptualizing and prototyping information products and services."

Among Sander's achievements in bioinformatics is the invention of GeneQuiz, a widely used suite of computational products for functional genomics, and other work in the development of software technology to analyze and predict the properties of proteins in living cells. He also played a key role in establishing EMBL's Department of Biocomputing.

"Chris's leadership in computational biology, genome analysis, and software development will enable Millennium Information to rapidly develop information products and services that effectively leverage Millennium's integrated technology platform into yet another important new business," commented Nick Galakatos, Millennium's vice-president for new businesses.

Filed under

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.